AB0481 Demonstrated, quantifiable benefits in patient reported outcomes supporting a “treat to target” paradigm for infliximab-treated RA patients previously inadequately responsiv... von Ingham, M., Tang, L., Decktor, D., Bolce, R., Wang, J.

Volltext

SAT0310 The effect of dactylitis and enthesitis on disease burden in patients with psoriatic arthritis in the corrona registry von Mease, P., Saunders, K., Bolge, S., Bolce, R., Decktor, D., Reed, G., Greenberg, J.

Volltext

PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF Treatme... von Ingham, M, Tang, L, Decktor, D, Bolce, R, Wang, J

Volltext

THU0181 Antibodies to Etanercept and Adalimumab in Rheumatoid Arthritis Inadequate Responders and Clinical Outcomes after an Active Switch to Infliximab von Pool, C., Shankar, G., Schantz, A., Gunn, G., Bolce, R., Leirisalo-Repo, M., Wang, J., Goldman, J., DeHoratius, R., Fleischmann, R., Decktor, D.

Volltext

PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid A... von Ingham, M, Ghushchyan, V.H, Reed, G, Decktor, D, Bolce, R, Bolge, S, Nair, K.V

Volltext

PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or Etanercept von Tandon, N, Bolce, R, Naim, A, Bolge, S, Ellis, L, Piech, C.T, Decktor, D

Volltext

MSR42 Innovative Real World Experience (RWE) Generation: Supplementing Registry Data with Patient Community Input for in-Depth Patient Understanding von Powell, V, Hernandez-Barco, YG, Barkin, JA, AlKaade, S, Pannala, R, Decktor, DL, Twal, J, Frommer, C, Whitcomb, DC

Volltext

SAT0204 Clinical and Radiographic Efficacy of Sarilumab in Rheumatoid Arthritis Patients with Varied Disease Duration von Emery, P., Decktor, D.L., Nguyen, D., Fan, C., Kavanaugh, A.

Volltext

FRI0186 Impact of Concomitant Methotrexate Dose on the Efficacy and Safety of Sarilumab for Treatment of Moderate-to-Severe Rheumatoid Arthritis: The Mobility Study von Huizinga, T.W.J., Yazici, Y., Thompson, D., Decktor, D.L., Fan, C., Fleischmann, R.

Volltext

SAT0198 Effect of Increased Sarilumab Dose on Efficacy and Safety Outcomes in Poorly Responding Rheumatoid Arthritis (RA) Patients: The Mobility Study von Genovese, M.C., Decktor, D.L., Parrino, J., Boddy, A., Graham, N.

Volltext

SAT0185 Clinical and Radiographic Efficacy of Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naïve Patients with Rheumatoid Arthritis in a Phase 3, Randomized, Do... von van der Heijde, D., Genovese, M.C., Fan, C., Fiore, S., Decktor, D.L., Fleischmann, R.

Volltext

The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration von Decktor, D, Houle, J M, Pierce, C H

Volltext

THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch von Huffstutter, J.E., Kafka, S., Brent, L.H., Matucci-Cerinic, M., Tang, K.L., Wang, J., Decktor, D.D., Chevrier, M., Sprabery, T., DeHoratius, R.

Volltext

Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis von ROBINSON, M., DECKTOR, D. L., MATON, P. N., SABESIN, S., ROUFAIL, W., KOGUT, D., ROBERTS, W., McCULLOUGH, A., PARDOLL, P., SACO, L., RUSTGI, V., KOVACSHU, T.

Volltext

Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis von Nishikawa, M., Owaki, H., Fuji, T., Soliman, M. M., Ashcroft, D. M., Watson, K. D., Lunt, M., Symmons, D., Hyrich, K. L., Atkinson, F., Malik, S., Heycock, C., Saravanan, V., Rynne, M., Hamilton, J., Kelly, C., Burmester, G., Kary, S., Unnebrink, K., Guerette, B., Oezer, U., Kupper, H., Dennison, E., Jameson, K., Hyrich, K., Watson, K., Landewe, R., Keystone, E., Smolen, J., Goldring, M., Patra, K., Cifaldi, M., van der Heijde, D., Lloyd, L. A., Owen, C., Breslin, A., Ahmad, Y., Emery, P., Matteson, E. L., Genovese, M., Sague, S., Hsia, E. C., Doyle, M. K., Fan, H., Elashoff, M., Kirkham, B., Wasco, M. C., Bathon, J., Fleischmann, R., Genovese, M. C., Liu, H., Goldman, J., Leirisalo-Repo, M., Zanetakis, E., El-Kadi, H., Kellner, H., Bolce, R., Wang, J., Dehoratius, R., Decktor, D., Kremer, J., Taylor, P., Mendelsohn, A., Baker, D., Kim, L., Ritchlin, C., Mariette, X., Matucci Cerenic, M., Pavelka, K., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., Iaremenko, O., Mikitenko, G., Kavanaugh, A., Luijtens, K., Curtis, J., Schiff, M., Kvien, T., Khanna, D., Furst, D., Behrens, F., Koehm, M., Scharbatke, E. C., Kleinert, S., Weyer, G., Tony, H.-P., Burkhardt, H., Blunn, K. J., Williams, R. B., Young, A., McDowell, J., Weinblatt, M., Haraoui, B., Mozaffarian, N., Khraishi, M., Alten, R., Gomez-Reino, J.

Volltext

Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase von Adelstein, Gilbert W, Yen, Chung H, Haack, Richard A, Yu, Stella, Gullikson, Gary, Price, Doreen V, Anglin, Charles, Decktor, Dennis L, Tsai, Henry, Keith, Robert H

Volltext

Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat von Decktor, Dennis L., Pendleton, Robert G., Elnitsky, Anne T., Jenkins, Ann M., McDowel, Anthony P.

Volltext

Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat von Fitzpatrick, L. R., Bostwick, J. S., Renzetti, M., Pendleton, R. G., Decktor, D. L.

Volltext

Gastroprotective and ulcer healing profile of the mast cell stabilizer quazolast in rats von Fitzpatrick, L. R., Decktor, D. L.

Volltext

Experience with omeprazole in erosive oesophagitis von ROBINSON, M. G., DECKTOR, D. L.

Volltext